Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Southwell David P
Relationship:   Chief Executive Office...
City:   Concord
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   337,703    

Indirect Shares

   1,650      
Direct Value   $3,259,103    

Indirect Value

   $51,447      
Total Shares   339,353      
Total Value   $3,310,550      


First Eagle Alternative Capital BDC, Inc $174,790 PTC Therapeutics, Inc. $400,663 Rocket Pharmaceuticals $2,683,650 Tscan Therapeutics, Inc. $0 First Eagle Alternative Capital BDC, Inc $174,790 PTC Therapeutics, Inc. $400,663 Rocket Pharmaceuticals $2,683,650 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
     0.0%
 -6.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Human Genome Sciences Inc HGSI Chief Financial Officer 2012-07-30 0 2009-03-13 0    Premium*  
            First Eagle Alternative Capital ... FCRD Director 2010-12-06 38,500 2010-11-16 0    Premium*  
            PTC Therapeutics, Inc. PTCT 2024-05-08 12,850 2024-05-08 1,650    Premium*  
            Rocket Pharmaceuticals RCKT 2024-04-15 114,784 2017-01-06 0    Premium*  
            Tscan Therapeutics, Inc. TCRX Chief Executive Office... 2022-05-18 171,569 2021-09-08 0    Premium*  
* Premium Members only  

Records found :    45         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTCT PTC Therapeutics, Inc. Director   –       •      –    2013-06-19 3 IO $0.00 $0 D/D 0 13,238 -
RCKT Rocket Pharmaceuticals Director   –       •      –    2018-04-02 4 OE $0.00 $0 D/D 21,875 38,535 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-11-28 4 OE $0.00 $0 D/D 153,125 191,660 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2020-01-29 4 A $0.00 $0 D/D 1,650 1,650 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2021-01-06 4 A $0.00 $0 D/D 1,650 3,300 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2022-01-07 4 A $0.00 $0 D/D 3,200 6,500 0 -
PTCT PTC Therapeutics, Inc.   –       •      –    2023-01-05 4 A $0.00 $0 D/D 4,000 10,500 0 -
PTCT PTC Therapeutics, Inc.   –       •      –    2024-02-15 4 A $0.00 $0 D/D 4,000 14,500 0 -
PTCT PTC Therapeutics, Inc.   –       •      –    2024-05-08 4 GD $0.00 $0 D/D 1,650 12,850 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-23 4 S $12.83 $1,283 D/D (100) 26,200 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-23 4/A B $12.83 $1,283 D/D 100 26,200 2.31 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-22 4/A B $12.82 $1,296 D/D 101 26,100 2.31 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-22 4 S $12.82 $1,296 D/D (101) 26,100 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-24 4 B $12.84 $2,568 D/D 200 26,400 2.31 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-07-12 4 A $32.86 $2,793 D/D 85 90,835 0 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-04-12 4 A $32.86 $3,187 D/D 97 73,097 0 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-19 4 B $12.83 $6,406 D/D 499 25,999 2.39 -
HGSI Human Genome Sciences Inc Director   –       •      –    2009-03-13 4 B $0.72 $52,341 D/D 73,000 73,000 2.39 -
FCRD First Eagle Alternative C... Director   –       •      –    2010-11-17 4 B $12.80 $70,324 D/D 5,478 14,100 2.39 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2014-03-21 4 AS $30.54 $71,666 D/D (2,317) 10,921 0 -
RCKT Rocket Pharmaceuticals   •       •      –    2018-12-07 4 S $14.91 $73,402 D/D (4,923) 133,928 0 -
TCRX Tscan Therapeutics, Inc. Chief Executive Officer   •       •      –    2022-05-18 4 B $3.55 $89,821 D/D 25,000 171,569 2.81 -
TCRX Tscan Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-12-23 4 OE $1.97 $95,880 D/D 48,670 146,569 0 -
TCRX Tscan Therapeutics, Inc. Chief Executive Officer   •       •      –    2021-09-08 4 B $8.73 $96,066 D/D 11,000 97,899 2.81 -
HGSI Human Genome Sciences Inc David Southwell   •       –      –    2010-06-01 4 OE $2.09 $101,731 D/D 17,653 90,750 0 -
  45  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us